Antibiotics (Basel)
January 2021
While antimicrobial resistance (AMR) is seen in both and , the former has become resistant to commonly available over-the-counter antibiotic treatments. It is imperative then to develop new therapies that combat current AMR isolates whilst also circumventing the pathways leading to the development of AMR. This review highlights the growing research interest in developing anti-virulence therapies (AVTs) which are directed towards inhibiting virulence factors to prevent infection.
View Article and Find Full Text PDF